Your shopping cart is currently empty

GAC0001E5 (1E5) is a dual LXR inverse agonist and degrader (IC50 = 5.4-9.1 μM in pancreatic cancer cells). It inhibits tumor growth and induces apoptosis by promoting LXRα/β degradation and suppressing transcriptional activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $970 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,500 | - | In Stock |
| Description | GAC0001E5 (1E5) is a dual LXR inverse agonist and degrader (IC50 = 5.4-9.1 μM in pancreatic cancer cells). It inhibits tumor growth and induces apoptosis by promoting LXRα/β degradation and suppressing transcriptional activity. |
| In vitro | In Western Blot, GAC0001E5 (1E5) reduced LXRα/β protein levels. It inhibited growth in AsPC-1, MiaPaCa-2, and BxPC-3 cells (IC50 = 8.0, 5.4, and 9.1 μM) and downregulated ABCA1 via qPCR[1]. |
| Molecular Weight | 331.29 |
| Formula | C17H12F3N3O |
| Cas No. | 927969-67-3 |
| Smiles | O=C1N=C(NC2=CC=CC(=C2)C(F)(F)F)NC(=C1)C=3C=CC=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (301.85 mM), Sonication is recommmended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.